$VRSK

Verisk Analytics (VRSK) Balances Lower Q2 Earnings With Buybacks and Dividends: What Story Does That Tell?

Verisk Analytics (VRSK) reported Q2 2026 revenue of $806.3M, up year over year, but net income fell to $228.6M. The company reaffirmed full-year 2026 revenue guidance of $3.19B to $3.24B and its $2.00 per share annual dividend. Verisk also continued buybacks totaling $7.27B since 2022 and named Nick Daffan as Strategic Advisor, with Jeff Negrete as interim CIO.

Original reporting
Published Aug 7, 2026, 4:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 9:46 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$VRSK
Neutral
medium confidence
Mentioned
$VRSK
Relevance
4/10
alphai data visualization · based on simplywall.st
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

The key tradable takeaway is the combination of higher revenue, lower net income, and unchanged full-year revenue guidance plus a confirmed $2.00 annual dividend, which frames investor expectations for steady growth rather than acceleration.

02

Market read

Guidance reaffirmation and ongoing buybacks/dividends likely reduce downside risk, but the article emphasizes valuation and leverage concerns if growth remains only moderate.

03

What to watch

The article flags AI execution (Claude integration) and pricing power, but provides no new metrics on those initiatives, leaving uncertainty around the durability of the premium multiple.

Relevance 4/10Novelty 4/10Timing: post-Q2 reporting, guidance reaffirmation and capital return narrative

Background

The piece summarizes Verisk’s Q2 2026 results, capital returns, and an orderly technology leadership transition.

Company-level read

Ticker impact

$VRSKNeutralMedium confidence
Context

Verisk reported Q2 2026 revenue of $806.3M, lower net income of $228.6M, and reaffirmed full-year revenue guidance of $3.19B to $3.24B.

Expected impact

Near-term trading likely hinges on whether investors view the reaffirmation as credible versus a sign of slower growth and margin pressure.

Evidence & confidence

The article provides specific Q2 results plus unchanged full-year guidance and $2.00 dividend, but it is framed as analysis rather than a new, market-moving disclosure beyond the reported quarter.

Market effects

Supports the view that insurance data and analytics franchises can sustain premium valuations if guidance remains steady despite margin fluctuations.

No specific regional spillover described.

No explicit global macro or cross-border catalyst described.

Counterpoint

Reaffirmed guidance may mask underlying margin pressure and leverage risk, meaning buybacks could be less supportive if growth stays modest.

Key entities

  • Verisk Analytics

    Reported Q2 2026 results with higher sales, lower net income, and reaffirmed full-year revenue guidance; continued buybacks and confirmed $2.00 annual dividend.

  • Nick Daffan

    Moved into a Strategic Advisor role; long-time technology executive change described as orderly.

  • Jeff Negrete

    Stepped in as interim Chief Information Officer.

Related articles

$VRSKMedAI 8/10

Verisk Analytics (VRSK) Q2 2026 Earnings Call Transcript

Verisk Analytics (NASDAQ:VRSK) reported Q2 2026 revenue of $806 million, up 4.3% reported and 5.8% organic constant currency. Adjusted EBITDA was $464 million, up 7.4% on the same basis. Subscription revenue was 83% of total, and diluted adjusted EPS was $1.98. Full-year guidance was reaffirmed: revenue $3.19B to $3.24B and EPS $7.45 to $7.75.

$VRSKMedAI 8/10

Verisk Ordered to Move Ahead With $2.35 Billion AccuLynx Merger

A Delaware Chancery Court judge ordered Verisk Analytics to proceed with its $2.35 billion merger with AccuLynx, rejecting AccuLynx’s bid to raise the deal price over antitrust clearance concerns. The judge cited willful conduct by AccuLynx for a failed closing condition and awarded AccuLynx damages for direct costs plus interest. The deal still requires HSR Act clearance and FTC approval.

$VRSKMedAI 8/10

[VRSK Q2 2026 Earnings Call] Verisk Q2 Organic Revenue Hits 5.8% as XactAI Users Jump 10x to 7,000, but Transactional Drag Persists — BigGo Finance

Verisk Analytics (VRSK) reported Q2 2026 revenue of $806 million, up 5.8% organic constant currency, driven by 8% subscription growth (83% of revenue). Transactional revenue fell 4.2% due to softer commercial property quotes and weaker weather demand. XactAI users rose 10x to 7,000. Full-year guidance of $3.19–$3.24B revenue and $1.79–$1.83B adj. EBITDA was reaffirmed.

$VRSKMed

Verisk Vaults on Releasing Q2 Results

Verisk (NASDAQ: VRSK) reported Q2 results for the quarter ended June 30, 2026. Net income fell 9.8% to $229 million, citing higher tax rate, net interest expense, and legal fees tied to litigation. The company paid a $0.50 dividend per share and launched a $200 million accelerated share repurchase, with an initial delivery of 949,190 shares at $179.10. Shares rose 9.6% to $221.87.